A.-S.S. Hamad Elgazwy / Polyhedron 28 (2009) 349–359
357
(quaternary C), 128.6 (CH), 127.5 (CH), 127.4 (quaternary C), 127.2
(CH), 127.0 (CH), 126.8 (CH), 126.4 (quaternary C), 124.7 (quater-
nary C), 124.7 (CH), 124.1 (CH), 123.1 (CH), 122.0 (quaternary C),
105.5 (quaternary C), 18.8 (2 ꢂ Me), 18.3 (2 ꢂ Me), 18.1 (2 ꢂ Me).
Anal. Calc. for C37H34N4O2 (566.7): C, 78.42; H, 6.05; N, 9.89. Found:
C, 78.36; H, 6.06; N, 9.87%.
ternary C), 135.6 (quaternary C), 134.9 (quaternary C), 132.7 (qua-
ternary C), 131.7 (CH), 129.11 (CH), 128.6 (CH), 127.54 (CH),
127.48 (quaternary C), 127.3 (CH), 126.8 (CH), 126.4 (CH), 124.0
(CH), 122.0 (CH), 112.9 (quaternary C), 57.34 (OMe), 18.8
(2 ꢂ Me), 18.3 (2 ꢂ Me), 18.1 (2 ꢂ Me). Anal. Calc. for C38H36N4O3
(596.7): C, 76.49; H, 6.06; N, 9.39. Found: C, 76.41; H, 6.02; N,
9.34%.
4.3. N-(2,6-Dimethylphenyl)-2-(2,6-dimethylphenylamino)-2-[2-(2,6-
dimethylphenyl)-7-methoxy-1-oxo-1,2-dihydro-pyrrolo[3,4-
b]quinolin-3-ylidene]-acetimidic acid (4b)
4.6. General Procedure of the ethyl esterification of acetamidic acids
(6a–b)
M.p.: 211–213 °C. IR (cmꢁ1):
(C@N) 1668. 1H NMR (200 MHz, CDCl3) d 8.79 (d, 1H, quinol-H4),
m
(OH),
mNH) 3420, 3232 b,
m(C@O),
Tl(TfO) (374 mg, 1.06 mmol) and EtOH (one drop) were added
to a solution of 3a–b (1.06 mmol) in CH2Cl2 (20 ml). The resulting
black suspension was stirred for 20 h and filtered over Celite, and
the yellow filtrate was concentrated and applied to a preparative
TLC plate (eluant: n-hexane/Et2O, 1:2), where two main yellow
bands separated. From the band at Rf = 0.25 a 2:1 mixture of
5a–b and 4a–b was obtained in moderate yield. The band at
Rf = 0.62 was collected and extracted with Me2CO (30 ml). The
extract was treated with anhydrous MgSO4 for 1 h, filtered and
evaporated to dryness, affording the yellow ester 6a–b in low
yields (18–19%).
m
4
3
8.42 (dd, 1H, JHH = 1.6, JHH = 8.7 Hz, quinol-H8), 7.97 (d, 1H,
3
3JHH = 8.7 Hz, quinol-H5), 7.73 (dd, 1H, JHH = 8.7 and 6.8 Hz, qui-
3
nol-H7), 7.43 (dd, 1H, JHH = 8.7 and 6.8 Hz, quinol-H6), 7.3–7.2
(m, 3H), 7.14–6.95 (m, 6H), 5.58 (s, 1H, NH), 3.96 (s, 3H, OMe),
2.39 (s, 2Me, 6H), 2.29 (s, 2Me, 6H), 1.63 (s, Me, 6H), 1.54 (s, 1H,
OH) ppm. 13C NMR (75 MHz, CDCl3) d 166.5 (C@O), 164.9 (quater-
nary C), 156.8 (quaternary C), 151.4 (quaternary C), 148.8 (quater-
nary C), 147.2 (quaternary C), 139.7 (quaternary C), 137.9 (CH),
131.1 (CH), 130.1 (CH), 129.9 (quaternary C), 129.7 (quaternary
C), 128.6 (CH), 127.5 (CH), 127.4 (quaternary C), 127.2 (CH),
127.0 (CH), 126.8 (CH), 126.4 (quaternary C), 124.7 (quaternary
C), 124.7 (CH), 124.1 (CH), 123.1 (CH), 122.0 (quaternary C),
105.5 (quaternary C), 57.34 (OMe), 18.8 (2 ꢂ Me), 18.3 (2 ꢂ Me),
18.1 (2 ꢂ Me). Anal. Calc. for C38H36N4O3 (596.7): C, 78.49;
H,6.06; N, 9.39. Found: C, 78.46; H, 6.04; N, 9.36%.
4.7. N-(2,6-Dimethylphenyl)-2-(2,6-dimethylphenylamino)-2-[2-(2,6-
dimethylphenyl)-1-oxo-1,2-dihydro-pyrrolo[3,4-b]quinolin-3-
ylidene]acetimidic acid ethyl ester (6a)
A suspension solution of 3a (871.32 mg, 1.06 mmol) in CH2Cl2
(20 ml) was used under the reaction conditions to produce 6a in
4.4. N-(2,6-Dimethylphenyl)-2-(2,6-dimethylphenylamino)-2-[2-(2,6-
dimethylphenyl)-1-oxo-1,2-dihydro-pyrrolo[3,4-b]quinolin-3-
ylidene]-acetamide (5a)
the yield 122 mg, 19%. M.p.: 210–212 °C. IR (cmꢁ1):
m
(NH) 3384,
m
(C@O), m
(C@N) 1698, 1694, 1660. 1H NMR (200 MHz, CDCl3) d
4
3
8.86 (d, 1H, quinol-H4), 8.34 (dd, 1H, JHH = 1.6, JHH = 8.4 Hz, qui-
nol-H8), 7.87 (d, 1H, JHH = 8.4 Hz, quinol-H5), 7.73 (dd, 1H,
3
M.p.: 146–148 °C. IR (cmꢁ1):
(C@O) 1698,
(C@N), 1668. 1H NMR (200 MHz, CDCl3) d 8.77 (d,
1H, quinol-H4), 8.37 (dd, 1H, JHH = 1.6, JHH = 8.6 Hz, quinol-H8),
m(NH) 3388, 3366, 3262 broad,
3JHH = 8.4 and 6.8 Hz, quinol-H7), 7.45 (dd, 1H, JHH = 8.4 and
3
m
m
6.8 Hz, quinol-H6), 7.10–7.05 (m, 3H), 6.80–6.69 (m, 6H), 4.79 (s,
4
3
2
NH, 1H), 4.39 (q, CH2Me, 2H, JHH = 7 Hz), 2.22 (s, 2 ꢂ Me, 6H),
3
3
2
7.97 (d, 1H, JHH = 8.6 Hz, quinol-H5), 7.73 (dd, 1H, JHH = 8.6 and
1.48 (bs, 4 ꢂ Me, 12H), 1.39 (t, CH2Me, 3H, JHH = 7 Hz) ppm. Anal.
3
6.9 Hz, quinol-H7), 7.43 (dd, 1H, JHH = 8.6 and 6.8 Hz, quinol-H6),
Calc. for C39H38N4O2 (594.7): C, 78.76; H,6.44; N, 9.42. Found: C,
78.74; H, 6.22; N, 9.35%.
7.30–7.21 (m, 3H), 7.14–6.96 (m, 6H), 6.89 (s, 1H, NH), 5.07 (s,
1H, NH), 2.44 (s, 2Me, 6H), 2.29 (s, 2Me, 6H), 2.02 (s, Me, 6H)
ppm. 13C NMR (75 MHz, CDCl3) d 165.8 (C@O), 162.6 (C@O),
157.8 (quaternary C), 147.8 (quaternary C), 146.8 (quaternary C),
139.8 (quaternary C), 139.6 (quaternary C), 137.8 (CH), 135.9 (qua-
ternary C), 135.7 (quaternary C), 135.6 (quaternary C), 134.9 (qua-
ternary C), 132.7 (quaternary C), 132.1 (CH), 131.9 (CH), 129.14
(CH), 129.11 (CH), 128.6 (CH), 127.54 (CH), 127.48 (quaternary
C), 127.3 (CH), 126.8 (CH), 126.4 (CH), 124.0 (CH), 122.0 (CH),
112.9 (quaternary C), 18.8 (2 ꢂ Me), 18.3 (2 ꢂ Me), 18.1 (2 ꢂ Me).
Anal. Calc. for C37H34N4O2 (566.7): C, 78.42; H, 6.05; N, 9.89. Found:
C, 78.31; H, 6.12; N, 9.84%.
4.8. N-(2,6-Dimethylphenyl)-2-(2,6-dimethylphenylamino)-2-[2-(2,6-
dimethylphenyl)-7-methoxy-1-oxo-1,2-dihydro-pyrrolo[3,4-
b]quinolin-3-ylidene]acetimidic acid ethyl ester (6b)
A suspension solution of 3b (903.12 mg, 1.06 mmol) in CH2Cl2
(20 ml) was used under the reaction conditions to produce 6b in
the yield 120 mg, 18%. M.p.: 206–208 °C. IR (cmꢁ1):
m
(NH) 3384,
m
(C@O), m
(C@N) 1698, 1694, 1660. 1H NMR (300 MHz, CDCl3) d
4
3
8.86 (d, 1H, quinol-H4), 8.34 (dd, 1H, JHH = 1.6, JHH = 8.4 Hz, qui-
nol-H8), 7.87 (d, 1H, JHH = 8.4 Hz, quinol-H5), 7.73 (dd, 1H,
3
3
3JHH = 8.4 and 6.8 Hz, quinol-H7), 7.45 (dd, 1H, JHH = 8.4 and
4.5. N-(2,6-Dimethylphenyl)-2-(2,6-dimethylphenylamino)-2-[2-(2,6-
dimethylphenyl)-7-methoxy-1-oxo-1,2-dihydro-pyrrolo[3,4-
b]quinolin-3-ylidene]-acetamide (5b)
6.8 Hz, quinol-H6), 7.10–7.05 (m, 3H), 6.80–6.69 (m, 6H), 4.79 (s,
2
NH, 1H), 4.39 (q, CH2, 2H, JHH = 7 Hz), 2.22 (s, 2 ꢂ Me, 6H), 1.48
2
(bs, 4 ꢂ Me, 12H), 1.39 (t, CH2Me, 3H, JHH = 7 Hz) ppm. Anal. Calc.
for C40H40N4O3 (624.8): C, 76.90; H, 6.45; N, 8.97. Found: C, 76.83;
H, 6.42; N, 9.02%.
Mp: 146–148 °C. IR (cmꢁ1):
(C@O) 1698,
(C@N), 1668. 1H NMR (200 MHz, CDCl3) d 8.77 (d,
1H, quinol-H4), 8.37 (dd, 1H, JHH = 1.6, JHH = 8.6 Hz, quinol-H8),
m(NH) 3388, 3366, 3262 broad,
m
m
4
3
4.9. X-ray crystallographic studies
3
3
7.97 (d, 1H, JHH = 8.6 Hz, quinol-H5), 7.73 (dd, 1H, JHH = 8.6 and
3
6.9 Hz, quinol-H7), 7.43 (dd, 1H, JHH = 8.6 and 6.8 Hz, quinol-
Details of data collection and refinement are given in Table 1.
The crystal structures from the single-crystal X-ray diffraction
studies for 2a, 3a and 3b were carried out on a Bruker SMART
H6),7.30–7.21 (m, 3H), 7.14–6.96 (m, 6H), 6.89 (s, 1H, NH), 5.07
(s, 1H, NH), 3.96 (s, 3H, OMe), 2.44 (s, 2Me, 6H), 2.29 (s, 2Me,
6H), 2.02 (s, Me, 6H), ppm. 13C NMR (75 MHz, CDCl3) d 165.8
(C@O), 162.6 (C@O), 158.8 (quaternary C), 154.8 (quaternary C),
148.8 (quaternary C), 143.8 (quaternary C), 139.8 (quaternary C),
139.6 (quaternary C), 136.9 (CH), 135.9 (quaternary C), 135.7 (qua-
1000 CCD diffractometer with graphite-monochromated Mo K
a
radiation (k = 0.71073 Å). Cell parameters were obtained by global
refinement of the positions of all collected reflections. Intensities
were corrected for Lorentz and polarization effects and empirical